Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Index funds provide broad diversification, low costs, and simple investment. They’re a solid foundation for long-term growth and reduced risk.
17,905 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Tracking your investments effectively starts with choosing the right tool. This guide breaks down the best tools for ...
The S&P 500 kicked off 2026 with a strong first half, delivering solid gains. This article breaks down what that coul...
A cost gap between IVW and cheaper growth peers may quietly erode returns over time. This analysis breaks down fees, ...
Choosing the right long-term bond ETF can reshape your portfolio's risk and income. This guide compares Vanguard's VC...
A hedge fund trend today centers on a lean, two-name portfolio. INDUS Capital Partners boosted its bet on H World Gro...
Can a defense-focused ETF outperform a jet-fueled recovery play in 2026? This deep dive examines PPA and JETS, weighi...
Tariffs announced by the administration sparked immediate market volatility and raised red flags for investors. This ...
Alphabet’s latest 13F filing hints at a notable shift in its investment palette. CME Group now sits atop Alphabet’s d...
Chip stocks were crashing after a period of strong earnings, leaving many investors puzzled. This article unpacks why...
A major stake sale can ripple through markets and portfolios. This article breaks down what arena capital sells milli...
A fresh recession signal has appeared. This guide breaks down what it means and outlines concrete steps you can take ...